Skip to content

Epoch BioDesign

Epoch, the Total BioDesign company

Catalysts For a Healthier Planet

Unprecedented vision, bold action and better solutions for a positive future.

At Epoch, we’re harnessing nature’s machines to solve our biggest climate challenges. We supercharge billions of years of evolution with modern biotechnology to develop enzymes that unlock applications previously deemed impossible. We have built a unique environment where AI scientists, chemists, engineers and enzyme biologists work side-by-side. This full-stack integration of expertise enables our team to build breakthrough approaches to designing and scaling biology like never before. 

Our passion is real

We come to work every day, knowing that we will have a significant positive impact on our planet. Our motivation comes from our mission and our people: clever, spirited, opinionated, authentic personalities that we learn from and have fun with!

  • Jacob Nathan

    Founder & CEO

  • Beatriz Lopez

    CPO

  • Ruth Aylward

    Platform Operations Scientist

  • Soumik Basu, PhD

    Synthetic Biologist

  • David Clayton

    Lab Technician

  • Charlotte Gruender, PhD

    Business Development Manager

  • Lucy Green, PhD

    Automation Scientist

  • Rachel Heath, PhD

    Head Of Assay Development

  • Giorgio Lai, PhD

    Scientist

  • Ben Mills-Lamptey, PhD

    Head Of Scale Up

  • Claire Noble, PhD

    Computational Biologist

  • Chloe Millson

    Lab Technician

  • Camila Gaspar Quinonez, PhD

    Assay Development Scientist

  • Jeremy Ramsden, PhD

    Scientist

  • Sreenivas Ravella, PhD

    Fermentation Scientist

  • Angela Sims, PhD

    R&D Operations Project Lead

  • Neil Swainston, PhD

    Head Of Computational Biology

  • Daryl Williams, PhD

    Biochemist

  • Mike Winn, PhD

    Senior Scientist – Biocatalysis